Vaccines and monoclonal antibodies are promising approaches for preventing and treating
infections caused by multidrug resistant Acinetobacter baumannii. However, only partial …

In parallel to the uncontrolled use of antibiotics, the emergence of multidrug-resistant
bacteria, like Acinetobacter baumannii, has posed a severe threat. A. baumannii …

Acinetobacter baumannii is an emerging opportunistic bacterium associated with
nosocomial infections in intensive care units. The alarming increase in infections caused by …

In the last decade, Multi-drug resistance (MDR)-associated infections of Acinetobacter
baumannii have grown worldwide. A cost-effective preventative strategy against this …

Background Acinetobacter baumannii has emerged as a significant nosocomial pathogen
during the last few years, exhibiting resistance to almost all major classes of antibiotics …

Abstract Acinetobacter baumannii (A. baumannii), an opportunistic, gram-negative
pathogen, has evoked the interest of the medical community throughout the world because …

Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

Nosocomial infections have become alarming with the increase of multidrug-resistant
bacterial strains of Acinetobacter baumannii. Being the causative agent in~ 80% of the …

Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …

Acinetobacter baumannii, a prominent pathogen responsible for chronic infections in the
blood, urinary tract, and lungs, has a high mortality due to its virulence and limited …